Skip to main content
. 2012 Mar 7;18(9):979–985. doi: 10.3748/wjg.v18.i9.979

Figure 2.

Figure 2

Growth inhibition assay of gastric cancer cells treated with oxaliplatin. Survival of gastric cancer cells is tested by 3-(4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. Each bar represents the mean ± SD. All experiments were repeated three times with similar results (aP < 0.05 vs MKN-45-NC, bP < 0.05 vs KATO-III-NCi).